Gomes, Sara Costa
Cavaliere, Carlo
Masieri, Simonetta
Van Zele, Thibaut
Gevaert, Philippe
Holtappels, Gabriele
Zhang, Nan
Ramasamy, Pathmanaban
Voegels, Richard Louis
Bachert, Claus http://orcid.org/0000-0003-4742-1665
Funding for this research was provided by:
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (Financial code 001, file 88887.570290/2020-00, 6685)
Article History
Received: 16 February 2022
Accepted: 23 May 2022
First Online: 6 June 2022
Declarations
:
: Carlo Cavalieri declares consultancy for GSK; Claus Bachert is an Advisory Board member and speaker for Novartis, GSK, Astra-Zeneca, Sanofi, ALK, and Mylan. Other authors have no conflict of interest.